STEM CELLS MARKET ANALYSIS

The global stem cells market is estimated to be valued at US$ 12.9 Bn in 2023 and is expected to exhibit a CAGR of 9.1% during the forecast period (2023-2030).

Analysts’ Views on Global Stem Cells Market :

Significant Research &Development expenditures are one of the major contributors to the market growth. Furthermore, the rising need for efficient therapies to lower the disease burden throughout the forecast period is another factor fueling the growth. For instance, Celavie Biosciences, a privately held company whose mission is to improve lives and restore hope by advancing regenerative stem cell therapies, completed its 5-year exploratory study on Parkinson's disease in May 2020. The company is working on regenerative stem cell therapies to treat Parkinson's disease and other central nervous system disorders. Celavie Biosciences announced that its preliminary clinical trials utilizing OK99 stem cells for Parkinson's disease were successful.

Figure 1. Global Stem Cells Market Share (%), by Type, 2023

To learn more about this report, request a free sample copy

Global Stem Cells Market – Driver

• Increasing collaborations, partnerships, and agreements: The increasing recognition of precision medicines is further promoting market growth. Scientists are finding new procurement methods that can be further utilized for the development of personalized medicines. For instance, induced pluripotent stem cells therapies are developed by utilizing a small amount of a sample from a patient’s skin or blood cell, which is later reprogrammed to form new tissue and cells for transplant. Moreover, in September 2022, Century Therapeutics, a biotechnology company that develops cell therapies for hematological and solid tumor malignancies, and Bristol-Myers Squibb Company, a U.S.-based multinational pharmaceutical company, announced a license agreement and research collaboration for the development and commercialization of Induced Pluripotent Stem Cells (iPSC)-derived allogeneic cell therapies. Hence, with the application of these cells coupled with strategic activities by market players, potential personalized medicines can be developed in the near future.
• Launch of novel technologies: The launch of novel technologies can drive the growth of the global stem cells market. For instance, in January 2021, REPROCELL Inc., a company that provides solutions for preclinical and clinical research, launched a new personalized induced pluripotent stem cells production service for generating patient-specific iPSC. The service will assist in the preparation and storage of an individual's iPSC for the development of regenerative medicines to treat future illnesses or injury. They are developed from mature cells using ready-to-use RNA reprogramming technology.

Figure 2. Global Stem Cells Market Share (%), by Region, 2023

To learn more about this report, request a free sample copy

Global Stem Cells Market - Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global stem cells market over the forecast period. This is because several countries in the region are making significant investments in the research of regenerative medicines. For example, in March 2020, the Government of Canada committed around US$ 6.9 million to regenerative medicine research. This grant will be used to support nine translational initiatives and four clinical trials targeted at creating novel regenerative medicine medicines. The new regenerative medications will help cure a wide range of blood ailments, heart illnesses, diabetes, and eyesight loss.  

Global Stem Cells Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, the U.A.E., Egypt, and others, are facing problems with the transportation of drugs from one place to another.

However, the COVID-19 pandemic had a positive impact on the global stem cells market. This was due to the surge in research and development activities that occurred during the pandemic. For instance, in August 2022, StemCyte India Therapeutics Pvt. Ltd., a biopharmaceutical company, obtained approval from the U.S. FDA for their Phase II clinical trial for Post-COVID Syndrome using umbilical cord blood stem cell therapy.

Global Stem Cells Market Segmentation:

The global stem cells market report is segmented into type, application, technology, and region.

• By Type, the market is segmented into adult stem cells, human embryonic stem cells, induced pluripotent stem cells, natural rosette cells, and very small embryonic like stem cells. Out of which, the adult stem cells segment is expected to hold a dominant position in the global stem cells market during the forecast period and this is because they are feasible for the usage.
• By Application, the market is segmented into regenerative medicine and drug discovery and development. Out of which, the regenerative medicine segment is expected to hold a dominant position in the global stem cells market during the forecast period due to their ability to heal tissues and organs and restore function lost due to aging, disease, damage, or defects.
• By Technology, the market is segmented into cell acquisition, cell production, cryopreservation, and expansion and sub-culture. Out of which, the cell acquisition segment is expected to dominate the market over the forecast period, and this is attributed to the varied and numerous applications of this technique.
• By Region, the market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Out of which, North America is expected to dominate the market over the forecast period and this is attributed to the increased R&D activities regarding stem cell in the region.

Among all the segmentations, the type segment is expected to have the highest potential due to the establishment of numerous centers regarding stem cells across the world over the forecast period. For instance, on May 25, 2023, CHA Medical & Bio Group, a global company that specializes in stem cell research based in South Korea, announced its plan to establish the CHA Power Aging Research Translational Institute (CHA PARTI) in Los Angeles, U.S. The institute will focus on advancing comprehensive stem cell treatments through stem cell and gene therapy.

Global Stem Cells Market Cross Sectional Analysis:

Among application, the regenerative medicine segment is expected to a dominant in the North America region due to the establishment of research and development institutes in the region. For instance, on April 26, 2023, The Icahn School of Medicine at Mount Sinai in New York, U.S. launched the Institute for Regenerative Medicine to encourage research into new pathways to cure a range of diseases from leukemia to Alzheimer’s disease, breast cancer, and airway diseases.

Global Stem Cells Market : Key Developments

•  On February 13, 2023, STEMBIOSYS, INC., a U.S.-based company that focuses on stem cell research, announced the launch of NeuroMatrix, an astrocyte-derived extracellular matrix that enables the culture of human induced pluripotent stem cell (hiPSC)-derived and primary neural cell types. STEMBIOSYS INC. designed NeuroMatrix to expand the use of iPSC-derived neurons in drug discovery and toxicity testing.
• On April 17, 2023, Gamida Cell, a cell therapy company working to turn cells into powerful therapeutics, announced that the U.S. Food and Drug Administration (FDA) had approved Gamida Cell’s allogeneic cell therapy, Omisirge (omidubicel-onlv), for use in adult and pediatric patients 12 years of age and older with hematologic malignancies. The therapy is planned for umbilical cord blood transplantation following myeloablative conditioning to reduce the time to neutrophil recovery and the incidence of infection. Omisirge allogeneic stem cell transplant therapy was approved on the basis of a global, randomized Phase 3 clinical study.

Global Stem Cells Market: Key Trends

• Key market players are adopting inorganic strategies like mergers, collaborations, and partnership agreements to help propel the growth of the global stem cells market over the forecast period. On June 13, 2023, STEMBIOSYS, INC. announced the launch of CELLvo Atrial Cardiomyocyte, a chamber-specific human induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) designed to function identically to human atrial cardiomyocytes.
• The establishment of new companies aimed at curing various diseases and disorders will help propel the growth of the stem cells market over the forecast period. In November 2022, Therapeutic Solutions International, Inc., a company focused on immune modulation for the treatment of several specific diseases, established a company called Breathe Biologics, which will aim to cure Chronic Obstructive Pulmonary Disease (COPD).

Global Stem Cells Market: Restraint

• Discrepancies in clinical trial data: The inability of investigational new drugs (IND) to produce effective results can restrain growth of the global stem cells market. For instance, on June 19, 2023, BioSenic SA, an innovative company with the objective of addressing important unmet medical needs in the areas of immunity, auto-immune diseases, and organ repair, halted a phase IIb trial for its allogeneic stem cell therapy, Allob, after it failed to accelerate healing when given to patients two days after they sustained tibial fractures. The company, thus, shifted its focus to its late-stage arsenic trioxide candidate for chronic graft-vs.-host disease (GVHD).  This restraint can be overcome by investing in data quality from the beginning of the trial and hiring biostatisticians to analyze the data.
• Lack of approval from the U.S. Food and Drug Administration (FDA): With the exception of a few approved treatments, the use of stem cells to treat illnesses has not reached the point where it is ready for widespread use in clinics. There are very few stem cell therapies that have been proven to be efficacious. There have been reports of adverse events as a result of stem cell therapies. Many businesses in the U.S. are marketing stem cell therapies that have not gone through the rigorous clinical trial process or been approved by the Food and Drug Administration (FDA). This can be overcome by reporting adverse drug reactions (ADRs) resulting from treatments at unregulated stem cell clinics around the world.

Global Stem Cells Market - Key Players

Major players operating in the global stem cells market include Advanced Cell Technology, Inc., Angel Biotechnology Holdings PLC, Biotricity, Lineage Cell Therapeutics, Inc., BrainStorm Cell Limited., CIRM, Celgene Corporation (A subsidiary of Bristol-Myers Squibb Company), Takara Bio Inc., Cellular Engineering Technologies., Cytori Therapeutics Inc., and STEMCELL Technologies.

Global Stem Cells Market – Definition

Stem cells are undifferentiated cells which are capable of differentiating into any type of cell that make-up the human body and thus, are capable of producing non-regenerative cells such as neural and myocardial cells.